Rubinstein Taybi syndrome
Rubinstein Taybi syndrome
Disease Overview
Rubinstein-Taybi syndrome (RTS) is a rare genetic disorder characterized by distinctive physical features, developmental challenges, and an increased risk of medical complications. The syndrome is marked by broad thumbs and toes, characteristic facial features, and varying degrees of intellectual disability.
Disease Category
Rare Genetic Disorder - Chromosomal Disorder - Congenital Malformation Syndrome
Synonyms
- Broad Thumb-Hallux Syndrome
- Rubinstein Syndrome
- RTS
Signs & Symptoms
Physical Characteristics: - Broad, angulated thumbs and big toes - Distinctive facial features - Beaked nose - Downward-slanting eyes - High arched palate - Prominent ears - Short stature - Microcephaly
Developmental and Cognitive Features: - Intellectual disability (mild to moderate) - Developmental delays - Speech and language challenges - Learning difficulties
Medical Complications: - Feeding difficulties in infancy - Increased risk of tumors - Congenital heart defects - Respiratory infections - Hearing and vision problems - Skeletal abnormalities
Causes
Genetic Mutations: - Mutations in the CREBBP gene (most common, ~55% of cases) - Mutations in the EP300 gene (~5% of cases) - Sporadic mutations (de novo)
Inheritance Pattern: - Autosomal dominant - Most cases occur as new (spontaneous) mutations
Affected Populations
- Prevalence: 1 in 100,000 to 1 in 125,000 live births
- Affects males and females equally
- No specific racial or ethnic predisposition
Disorders with Similar Symptoms
- Floating-Harbor syndrome
- Cornelia de Lange syndrome
- Coffin-Siris syndrome
- Dubowitz syndrome
- KBG syndrome
Diagnosis
Diagnostic Approach: - Comprehensive clinical evaluation - Physical examination - Genetic testing - Molecular genetic testing - Chromosomal microarray analysis - Imaging studies (heart, skeletal) - Developmental assessments
Diagnostic Criteria: - Characteristic physical features - Genetic mutation confirmation - Developmental evaluation
Standard Therapies
Medical Management: - Regular medical monitoring - Treatment of specific medical complications - Cardiac evaluation - Hearing and vision screenings
Therapeutic Interventions: - Early intervention programs - Physical therapy - Occupational therapy - Speech and language therapy - Educational support - Behavioral therapy
Clinical Trials and Studies
- Ongoing research into genetic mechanisms
- Studies exploring potential targeted therapies
- Longitudinal studies tracking developmental outcomes
References
- National Institutes of Health (NIH)
- Online Mendelian Inheritance in Man (OMIM)
- Genetic and Rare Diseases Information Center
Programs & Resources
- The Rubinstein-Taybi Syndrome Network
- National Organization for Rare Disorders (NORD)
- Genetic and Rare Diseases Information Center (GARD)
- Support groups and patient advocacy organizations
Complete Report
Comprehensive medical information available through specialized genetic counseling centers, rare disease organizations, and medical genetics specialists.